PRISM BioLab Achieved Initial Milestone and Receives the Milestone Payment in Drug Discovery Collaboration with Ono Pharmaceutical Co., Ltd.
“We are delighted to have achieved the first milestone in drug discovery research targeting previously challenging targets identified by Ono.”, said Dai Takehara, President & CEO of PRISM BioLab.